Fig. 3From: Concurrent estimation of lamivudine, tenofovir disoproxil fumarate, and efavirenz in blended mixture and triple combination tablet formulation by a new stability indicating RP-HPLC methodLinearity curve of LAM, EVZ, and TDFBack to article page